Next-generation sequencing (NGS), massively parallel or deep sequencing is a related term describing DNA sequencing technology that has revolutionized genome research. The development of sequencing-based chromatin analysis technology allows current researchers to experimentally measure the properties of chromatin. NGS is the choice for large-scale genome and transcriptome sequencing. This is because the high-throughput sequencing data generated and output by each instrument is in the gigabyte range, and the cost is compared with the traditional Sanger first-generation sequencing method.
The difference between NGS technology and Sanger method is that they provide large-scale parallel analysis, which can provide ultra-high throughput of multiple samples at a greatly reduced cost. Millions to billions of DNA nucleotides can be sequenced in parallel, which significantly increases yields and minimizes the need for fragment cloning methods used in Sanger Sequencing.
Title : The era of artificial intelligence (AI) and its use in regenerative medicine
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : The role of gingival fibroblasts in periodontal diseases and regeneration
Katarzyna Gawron, Medical University of Silesia in Katowice, Poland
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Role of textile materials in tissue engineering and regenerative medicine
Gokarneshan Narayanan, SSM College of Engineering (Formerly), India
Title : Induction of neo angiogenesis: A way forward for reversing necrosis in complex wounds in orthopaedic practice
Sandeep Shrivastava, Datta Meghe Institute of Medical Sciences, India
Title : Silk-derived sericin at the interface of atopic dermatitis and wound healing: Modulation of inflammation and epidermal repair
Marek Konop, Medical University of Warsaw, Poland